Shareholding disclosure

BB Biotech AG

Declared position

3%

Threshold

Fell below threshold

Timeline

Published

04.03.2010

Transaction

26.02.2010

Transfer date

11.03.2010

Voting rights breakdown

Voting rights acquired0%
Voting rights sold0%
Below threshold3%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAA3300057

Beneficial owner

BB Biotech AG

Declared address

BB Biotech AG, 8200 Schaffhausen

Registration of shares held within the exchange offer of Cosmo Pharmaceuticals ot the shareholders of BioXell Biotech Growth NV is a wholly owned subsidiary of BB Biotech AG, Schaffhausen

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open